What is IDH1 mutation?
IDH1 mutations are heterozygous, typically involving an amino acid substitution in the active site of the enzyme in codon 132. The mutation results in a loss of normal enzymatic function and the abnormal production of 2-hydroxyglutarate (2-HG).
What causes IDH1 mutation?
IDH mutations are found in about one-quarter of people with acute myeloid leukemia (AML), the most common type of leukemia in adults. They may also be found in a type of bile duct cancer called cholangiocarcinoma, a bone cancer called chondrosarcoma, low-grade glioma, and some kinds of lymphoma.
Is IDH2 reversible?
Importantly, IDH1 and IDH2 catalyze reversible reactions and have no known allosteric modifiers, whereas the reaction catalyzed by IDH3 is irreversible and allosterically regulated by a variety of positive (calcium, ADP, and citrate) and negative (ATP, NADH, and NADPH) effectors (1).
Is IDH1 mutation good?
Based on the review of current literature IDH1 mutation is an independent factor for longer overall survival (OS) and progression free survival (PFS) in GBM patients when compared to wild-type IDH1. The prognostic significance opens up new avenues for treatment.
What does IDH1 wild type mean?
As a reversible dehydrogenase, wild-type IDH1 is a homodimeric enzyme that reversibly catalyzes isocitrate into α-KG accompanied with the generation of NADPH from NADP+ in cytosol, which has been proven to be physiologically crucial in the metabolism of lipids, amino acids, and sugars in cells.
Is IDH1 a tumor suppressor?
IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response.
What is IDH1 and IDH2?
Isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) are key metabolic enzymes that convert isocitrate to α-ketoglutarate. IDH1/2 mutations define distinct subsets of cancers, including low-grade gliomas and secondary glioblastomas, chondrosarcomas, intrahepatic cholangiocarcinomas, and hematologic malignancies.
What does IDH1 negative mean?
Tumors with normal IDH genes referred to as “IDH wild-type” or “IDH negative” tend to behave far more aggressively. Prognosis of IDH wild-type low-grade gliomas is similar to that of primary GBM 1.
What does IDH1 wild-type mean?
What is IDH1 wild-type?
What is the role of IDH mutations in acute myeloid leukemia?
Mutations in IDH1 or IDH2 are detected in approximately 20% of patients with acute myeloid leukemia (AML) and induce amino acid changes in conserved residues resulting in neomorphic enzymat … The role of IDH mutations in acute myeloid leukemia
Is IDH1 mutation an inclusion criterion in clinical trials for lymphoma?
IDH1 Mutation is an inclusion criterion in 3 clinical trials for lymphoma, of which 1 is open and 2 are closed. Of the trials that contain IDH1 Mutation and lymphoma as inclusion criteria, 2 are phase 1 (0 open) and 1 is phase 2 (1 open) [ 5 ].
Are idh1r132 and idh2r172 mutations mutations mutually exclusive in AML?
IDH1R132 and IDH2R172 mutations were mutually exclusive. Concurrent mutations in NPM1, FLT3, CEBPA, and NRAS were detected only in AML with the IDH1R132 mutation. The clinical and laboratory variables of patients with AML with IDH mutations showed no significant differences compared with patients with wild-type IDH.
Is IDH1 mutation an inclusion criterion for anaplastic astrocytoma?
IDH1 Mutation is an inclusion criterion in 3 clinical trials for anaplastic astrocytoma, of which 2 are open and 1 is closed. Of the trials that contain IDH1 Mutation and anaplastic astrocytoma as inclusion criteria, 2 are phase 1 (1 open) and 1 is phase 3 (1 open) [ 5 ].